Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this randomized, placebo-controlled double-blind trial is to evaluate efficacy
of acetazolamide in preventing overt altitude-related adverse health effects (ARAHE) in
lowlanders with chronic obstructive pulmonary disease (COPD) developing early signs of
altitude-illness during altitude travel.
Phase:
Phase 3
Details
Lead Sponsor:
University of Zurich
Collaborator:
National Center of Cardiology and Internal Medicine, Kyrgyz Republic